Figure 3.
MALDI-TOF spectrum of N-glycans. (A) LC-MS/MS of O-glycans released from human platelets, showing extracted ion chromatogram. The peaks were collected, and each structure was confirmed by MSn (Table 3). (B) MSn disassembly of isomeric fucosylated O-glycans isolated by high-performance LC (m/z 1518.9) with spectral match of Fuc(α1,2) Gal, from the standard LNFP-I (lacto-N-fucopentaose I) in MSn. (C) Quantification of released O-glycans, classified by sialylation status (neutral/asialo-, monosialylated, or disialylated) was performed by extracted ion chromatographs. Example structures are depicted, with the conclusive list of structures quantified found in Table 3.

MALDI-TOF spectrum of N-glycans. (A) LC-MS/MS of O-glycans released from human platelets, showing extracted ion chromatogram. The peaks were collected, and each structure was confirmed by MSn (Table 3). (B) MSn disassembly of isomeric fucosylated O-glycans isolated by high-performance LC (m/z 1518.9) with spectral match of Fuc(α1,2) Gal, from the standard LNFP-I (lacto-N-fucopentaose I) in MSn. (C) Quantification of released O-glycans, classified by sialylation status (neutral/asialo-, monosialylated, or disialylated) was performed by extracted ion chromatographs. Example structures are depicted, with the conclusive list of structures quantified found in Table 3.

Close Modal

or Create an Account

Close Modal
Close Modal